Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.72
Bid: 9.73
Ask: 10.18
Change: -0.195 (-1.97%)
Spread: 0.45 (4.625%)
Open: 9.72
High: 9.72
Low: 9.72
Prev. Close: 9.915
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2021 MREL Requirement

1 Jun 2021 07:00

RNS Number : 3047A
Banco Bilbao Vizcaya Argentaria SA
01 June 2021
 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, hereby communicates the following:

INSIDE INFORMATION

BBVA has received a new communication from the Bank of Spain regarding its minimum requirement for own funds and eligible liabilities ("MREL"), as determined by the Single Resolution Board ("SRB"), that has been calculated taking into account the financial and supervisory information as of December 31, 2019[1], and which supersedes the previous MREL communication published on November 19, 2019.

In accordance with this new MREL communication, BBVA has to reach, by January 1, 2022, an amount of own funds and eligible liabilities equal to 24.78%[2] of the total risk weighted assets ("RWAs") of its resolution group, on sub-consolidated level[3] (the "MREL in RWAs"). Within this MREL in RWAs, an amount equal to 13.50%2 of the RWAs shall be met with subordinated instruments (the "subordination requirement in RWA").

This MREL in RWA is equal to 10.25% in terms of the total exposure considered for calculating the leverage ratio (the "MREL in LR"), while the subordination requirement in RWAs is equal to 5.84% in terms of the total exposure considered for calculating the leverage ratio (the "subordination requirement in LR").

The current own funds and eligible liabilities structure of the resolution group meets the MREL in RWAs, the MREL in LR, the subordination requirement in RWAs and the subordination requirement in LR.

 

MREL

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

24.78%

10.25%

Own funds and eligible liabilities as of March 31, 2021

29.23%[4]

13.40%

 

Subordination requirement

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

13.50%

5.84%

Own funds and eligible subordinated liabilities as of March 31, 2021

25.95%4

11.89%

 

 

Madrid, May 31, 2021

 

[1] As the reference date used for the calibration of the MREL has been December 31, 2019, the effects, among other issues, of the expected sale of the BBVA Group subsidiary BBVA USA Bancshares, Inc, which was announced to the market on November 16, 2020, have not been taken into account.

[2] In accordance with the new applicable regulation, the MREL in RWAs and the subordination requirement in RWAs do not include the combined capital buffer requirement. For these purposes, the applicable combined capital buffer requirement would be 2.5%, without prejudice to any other buffer that may be applicable at any time.

[3] Pursuant to BBVA Group's MPE (Multiple Point of Entry) resolution strategy, as established by the SRB, the resolution group consists of Banco Bilbao Vizcaya Argentaria S.A. and the subsidiaries that belong to the same European resolution group. As of December 31, 2019, the RWAs of the resolution group amounted to 204,218 million euros and the total exposure considered for calculating the leverage ratio amounted to 422,376 million euros.

[4] Own funds and eligible liabilities to meet both MREL in RWAs or subordination requirement in RWAs, as applicable, and the combined capital buffer requirement, which would be 2.5%, without prejudice to any other buffer that may apply at any time.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAUKRAWUVOAR
Date   Source Headline
26th Apr 20132:40 pmRNSPublication of Financial Statements
26th Apr 20138:52 amRNS1st Quarter Results: Analysts presentation
26th Apr 20137:19 amRNS1st Quarter: Press release and group information
24th Apr 20137:00 amRNSSale in Peru: AFP Horizonte S.A.
22nd Apr 20136:17 pmRNSDividend option: trading period has ended today
22nd Apr 20136:04 pmRNSBBVA Results for 1Q 2013 will be presented
22nd Apr 20137:00 amRNSChanges in the structure of the information
19th Apr 20137:00 amRNSSale in Colombia
3rd Apr 20136:12 pmRNS"Dividend option" free-of-charge capital increase
22nd Mar 20135:32 pmRNSCONVERTIBLE BONDS
20th Mar 20135:26 pmRNSDividend Option
15th Mar 20134:07 pmRNSResult of AGM: RESOLUTION PASSED
1st Mar 20135:20 pmRNSReinsurance agreement
8th Feb 201310:29 amRNSRemuneration policy of the BBVA Board of Directors
8th Feb 201310:22 amRNS2012 Annual corporate governance report
8th Feb 20138:23 amRNSProposed resolutions and the directors' report
1st Feb 20134:22 pmRNSStabilisation Notice
1st Feb 20137:24 amRNSPress release and group information 2012
1st Feb 20137:00 amRNSCHILE: Agreement for the sale of AF Provida
31st Jan 20136:23 pmRNSAGM Statement
30th Jan 20137:00 amRNSPotential sale in Chile
28th Jan 20135:13 pmRNSResults of BBVA for 4Q 2012 wil be presented
25th Jan 20135:23 pmRNSCONVERTIBLE BONDS
9th Jan 20136:14 pmRNSBBVA: Sale in México
24th Dec 201210:47 amRNSSale in Colombia
21st Dec 20122:03 pmRNSBBVA Global Finance: Amended Final Terms
21st Dec 20121:49 pmRNSBBVA Global Finance: Results of Adjourned Meeting
19th Dec 20126:26 pmRNSThird interim dividend against 2012 results
18th Dec 20125:25 pmRNSSale in Puerto Rico
3rd Dec 20124:25 pmRNSBBVA Global Finance: Notice of Adjourned Meeting
3rd Dec 20124:17 pmRNSBBVA Global Finance: Results of Meeting
28th Nov 20127:00 amRNSSale of Administradora Fondos Retiro Bancomer
21st Nov 201211:23 amRNSHolders Spanish Consent Securities: Results
13th Nov 201212:19 pmRNSDividend option: Application for Admission
6th Nov 20125:26 pmRNSChanges Executive Committee of the BBVA
31st Oct 20128:48 amRNS3rd Quarter Results: Analysts presentation
31st Oct 20127:28 amRNS3rd Quarter Results year 2012
30th Oct 20124:26 pmRNSNotice of a meeting of the noteholders
30th Oct 20127:00 amRNSNon-Consent Securities: Results
26th Oct 20125:31 pmRNSPresentation Results 3r Quarter:On October 31st
22nd Oct 20127:00 amRNSUNNIM: Offer to purchase
16th Oct 20125:11 pmRNSUNNIM: Supplement to the tender offer
16th Oct 201212:19 pmRNSS&P: Modification of BBVA´s rating
15th Oct 20125:19 pmRNSDividend option: Trading period ended October 15
11th Oct 201212:42 pmRNSSECURITIES: Invitations to holders
3rd Oct 20126:32 pmRNSEuropean Banking Authority (EBA)
28th Sep 20126:27 pmRNSResults of the Spanish banking sector stress test
28th Sep 201211:54 amRNSUNNIM: Tender offer to the holders
27th Sep 20127:00 amRNSDividend option: CAPITAL INCREASE
27th Sep 20127:00 amRNSAppointment: Audit and Compliance Committee

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.